Envista
Dr. Aimee Margaux Greco is an experienced regulatory affairs professional with a strong background in quality assurance and program management. Currently serving as Vice President of Regulatory Affairs at Envista Corporation, Dr. Greco has previously held senior leadership positions at Takeda, where responsibilities included Senior Director of Regulatory Affairs CMC and Head of Drug Delivery, as well as roles at Shire Pharmaceuticals and Baxalta, focusing on combination products and medical devices. Additionally, Dr. Greco served as Regulatory Lead for the Medical Device Business Unit at 3M, demonstrating extensive expertise in the regulatory landscape for medical products.
This person is not in any teams
This person is not in any offices
Envista
7 followers
Envista Holdings Corporation is a dental products company. The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.